Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Bone Neoplasms 2Thrombocytopenia 1Skin Neoplasms 1Sarcoma 1Neoplasms 1Leiomyoma 1Hemostatic Disorders 1Hemorrhage 1Breast Neoplasms 1

Interventions

eltrombopag 4Platelet Transfusion 4romiplostim 2Cytarabine 2Cyclophosphamide 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1pegfilgrastim 1niraparib 1fludarabine 1etoposide phosphate 1Vorinostat 1Tranexamic Acid 1Temozolomide 1Stem Cell Transplantation 1Saline Solution 1Rituximab 1Radiotherapy 1Pharmacokinetics 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Comparative Genomic Hybridization 1Carboplatin 1Busulfan 1Aspirin 1Amplified Fragment Length Polymorphism Analysis 1Aminocaproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thrombocytopenia × Tranexamic Acid × Clear all
NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡